Clinicians in all fields of medicine, including psychiatry, have become acutely conscious of the problems posed by the threat of liability. In psychopharmacology, courts and attorneys are able to understand and see some of the concrete actions of the pharmacological agents, in contrast to the relatively cloudy effects of psychotherapy, thus increasing the likelihood of litigation. In this context, clinicians must understand the medicolegal issues that surround, limit, and influence their practice of psychopharmacology.
KeywordsTardive Dyskinesia Therapeutic Alliance Informed Consent Process Refuse Treatment Competent Patient
Unable to display preview. Download preview PDF.
- 1.Gutheil T. G., Appelbaum P. S.: Clinical Handbook of Psychiatry and the Law. New York, McGraw-Hill, 1982.Google Scholar
- 5..For example, see Stensvad v Reivitz (D.C. Wisc. 84-C-383–5, Jan. 10, 1985).Google Scholar
- 6..Youngberg v Romeo 50 U. S. L. W. 4681 (June 15, 1982).Google Scholar
- 7..For example, see Rivers v Katz 495 N.E.2d 337 (N.Y., 1986).Google Scholar